Alterity Therapeutics
Price & Volume
Stats
See more52W Range | $2.52-$7 |
Market Cap | $60.2M |
Shares Short | 1,615 |
Financials
See moreRevenue (12 Mos) | $5.4M |
Revenue Growth (YoY) | 80.9% |
Gross Profit (12 Mos) | $5.3M |
Diluted EPS | -$0.59 |
News
See moreYahoo Finance • 3 months ago
Alterity Therapeutics to Present at the Bell Potter Healthcare Virtual Conference
Yahoo Finance • 5 months ago
Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
Yahoo Finance • 5 months ago
Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders
Yahoo Finance • 5 months ago
Alterity Therapeutics Presents ATH434-201 Phase 2 Data at the American Neurological Association Annual Meeting
About
CEO | Dr. David A. Stamler M.D. |
CFO | Ms. Abby Macnish Niven B.Com., B.Sc., C.F.A. |
Address | 350 Collins Street, Melbourne, VIC, Australia, 3000 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |
